A second CD19 CAR T-cell infusion: yes or no?
نویسندگان
چکیده
منابع مشابه
Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
BACKGROUND Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered the cornerstone in treatment of hematological malignancies. However, relapse of the hematological disease after allo-HSCT remains a challenge and is associated with poor long-term survival. Chimeric antigen receptor redirected T cells (CAR-T cells) can lead to disease remission in patients with relapsed/refr...
متن کاملPheochromocytoma: yes or no?
A 76-year-old woman was admitted for cardiac decompensation, hypertension, and renal failure. To explore her chronic hypertension, urinary fractionated metanephrines were quantified. Fig. 1A shows the chromatogram of the patient’s urine, and Fig. 1B shows the chromatogram of a calibration standard. A very large methoxytyramine peak was observed (Fig. 1A, black arrow). The peak signal was satura...
متن کاملCognitive impairment: yes or no?
value cannot rule out the possibility that some area in the brain may be hypoxic or ischemic. We agree that this is a major limitation of the method. However, the same triticism could be brought against the measurement of cerebral oxygenation by methods that monitor a very limited cerebrd area, such as near-infrared spectroscopy (NIRS) or direct cerebral oxygen measurement with intracerebra1 pr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Blood
سال: 2021
ISSN: 0006-4971,1528-0020
DOI: 10.1182/blood.2020009206